Do you want to read an article? Please log in or register.
RAPSON: 223Ra before chemotherapy shows clinical benefit in patients with bone-dominant mCRPC
Genitourinary Cancer
ESMO 2024
Related content
ESMO 2024
Genitourinary Cancer
223Ra followed by 177Lu-PSMA was clinically feasible in heavily pretreated patients with mCRPC in clinical practice
ASCO 2024
Genitourinary Cancer
PSMAfore: 177Lu-PSMA-617 improved time to worsening in HRQoL and pain in taxane-naïve patients with PSMA-positive mCRPC
SPECIAL REPORT
Lymphoma
Real-World Comparison of YESCARTA® and Liso-Cel in 2L+ Among Patients with R/R DLBCL and HGBL
SPECIAL REPORT
Breast Cancer
Results of TRODELVY® real-world data
COMMENTED
Genitourinary CancerNuclear Medicine
Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study)
★ 1
Recommended and commented by
Prof. Dr Ken Herrmann, Faculty Member
Eur J Nucl Med Mol Imaging
Rosar F, Schuler J, Burgard C, Blickle A, Bartholomä M, Maus S, Petto S, Khreish F, Schaefer A, Ezziddin S
doi: 10.1007/s00259-024-06825-4
ASH 2024
Lymphoma
Liso-cel is effective and safe in a broad real-world population of R/R LBCLa patients, including second-line setting and secondary CNS involvement
WCLC 2024
Lung, Respiratory and Thoracic Cancer
TROPION-Lung01: Datopotamab deruxtecan shows a clinically meaningful trend toward improved OS versus docetaxel in patients with NSCLC
EHA 2024
Lymphoma
STARGLO: Glofitamab combination therapy shows significant benefits in patients with relapsed/refractory diffuse large B-cell lymphoma
Further Publications
Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer
Eur J Cancer
Roubaud G, Attard G, Boegemann M, Olmos D, Trevisan M, Antoni L, Pascoe K, Capone C, Van Sanden S, Hashim M, Palmer S, Chi K
doi: 10.1016/j.ejca.2024.114183